CDMO partner delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals.
Shilpa Pharma provides end-to-end pharmaceutical development and manufacturing, supporting clients from early development to commercial-scale manufacturing. Its stated areas of expertise include oncology APIs, formulations, peptides, polymers, and biologics.
CAS No. 86639-52-3; DNA Topoisomerase I Inhibitor (Active metabolite of Irinotecan).
Source & evidence
Supplier website SN-38 86639-52-3 DNA Topoisomerase I Inhibitor (Active metabolite of Irinotecan) Enquire Now Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Sequence feasibility and synthesis strategy selection; resin, linker, and protecting-group optimization; process optimization; impurity profiling; salt-form selection; lyophilization development; and technology transfer to GMP.
Source & evidence
Supplier website Key services include: Sequence feasibility analysis and synthesis strategy selection (SPPS vs. LPPS vs. hybrid) Resin, linker, and protecting-group strategy optimization (Fmoc / Boc) Fragment-condensation design for long and complex peptides Process optimization using DoE and Quality-by-Design (QbD) Peptide-related impurity profiling and control strategy (deletion, truncated, insertion sequences, D-isomers, aggregation) Counter-ion exchange and salt-form selection (acetate, hydrochloride, TFA removal) Lyophilization cycle development and solid-state characterization Technology transfer from research to GMP Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Analytical Method Development & Validation
Develops HPLC and GC methods and validates analytical methods for raw materials, intermediates and APIs; also develops and validates methods for detoxification and decomposition analysis of oncology APIs.
Source & evidence
Supplier website Analytical Method Development & Validation - as per ICH /ANVISA HPLC & GC Develop analytical methods using HPLC and GC for raw materials, intermediates, and NCE/API characterization. Detoxification Studies Develop and validate methods for detoxification and decomposition analysis of oncology APIs ensuring accuracy and reliability. Method Validation Validate analytical methods as per ICH and ANVISA guidelines for raw materials, intermediates, and APIs. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Regulatory Documentation and Filing Support
Support includes US FDA DMF preparation and filing, European EDMF and CEP applications, Japanese JDMF support, IMPD preparation, CTD dossier compilation, and responses to deficiency letters.
Source & evidence
Supplier website US FDA Drug Master File (DMF) preparation and filing European Drug Master File (EDMF) and Certificate of Suitability (CEP) applications Japanese Drug Master File (JDMF) support IMPD (Investigational Medicinal Product Dossier) preparation CTD-format technical dossier compilation Regulatory response support for deficiency letters Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Analytical Testing
Quality control testing for raw materials, intermediates and APIs, plus specification and testing procedure support, thermal analysis, particle size analysis and ion-chromatography analysis.
Source & evidence
Supplier website Quality control testing (Assay, Related substances, Residual solvents, Wet chemical analysis, etc.) for Raw materials, Intermediates and APIs as per customer specification › Quality control testing as per compendial monograph specification › Proposal, review and finalization of Specification along with Standard Testing Procedure (STP) › Thermal analysis › Particle size analysis › Ion-Chromatography analysis Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Analytical and quality control services
Analytical testing and quality control including impurity profiling, structural and solid-state characterization, microbiology testing and stability studies.
Source & evidence
Supplier website Our QC capabilities include: Chromatographic Analysis: HPLC, UPLC, GC, and LC-MS for precise impurity profiling and quality testing Structural & Solid-State Characterization: XRD, DSC, and spectroscopy for in-depth material analysis Microbiology & Contamination Control: Dedicated microbiology labs for sterility and bioburden testing Environmental Control: Clean rooms with HEPA filters ensuring contamination-free production Stability Studies: ICH-compliant stability chambers for long-term and accelerated stability testing Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Photo-Stability & Forced Degradation Study
Studies degradation pathways and mechanisms, the stability-indicating nature of methods, and chemical properties of drug molecules under ICH conditions.
Source & evidence
Supplier website Forced degradation studies to showcase the specificity of stability indicating methods and gather essential data for determination of proper storage conditions, packaging and shelf life of product, which are vital for regulatory documentation Establishing degradation pathways of drug substances Revealing degradation mechanisms such as hydrolysis, oxidation, thermolysis or photolysis Establishing degradation pathways of drug substances Establishing the stability-indicating nature of a developed method Understanding the chemical properties of drug molecules Creating a degradation profile similar to formal stability studies under ICH conditions Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Impurity Evaluation & Impurity Profiling
Includes identification of unknown impurities by LCMS and GCMS and quantification of nitrosamine, non-carryover, genotoxic and elemental impurities.
Source & evidence
Supplier website Unknown impurities identification by mass spectroscopy - LCMS & GCMS Nitrosamine impurities quantifications Non-carryover impurities quantifications Genotoxic impurities quantifications Elemental Impurities quantifications (ICP-OES/MS) – as per ICH Q3D Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
ADC payload development support
Support includes process optimization, analytical characterization, solid-state engineering, scalable manufacturing, and secure global shipment.
Source & evidence
Supplier website As a trusted partner for ADC payload development and bulk supply, we provide complete support — from process optimization, analytical characterization, and solid-state engineering to scalable manufacturing and secure global shipment. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Peptide CDMO
End-to-end peptide development and manufacturing, from building blocks to final API, with peptide purification and lyophilization capabilities.
Source & evidence
Supplier website End-to-end peptide development and manufacturing - from building blocks to final API Our specialized infrastructure for high-purity peptide synthesis, peptide purification and lyophilization capabilities include: Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Polymorph Profiling
Evaluates and identifies polymorphs, screens and qualifies polymorphic forms, and quantifies and establishes polymorphic nature in NCE/API.
Source & evidence
Supplier website Evaluation & Identification of Polymorphs Systematic analysis of solid-state forms to identify potential polymorphs and assess stability characteristics. 2 Polymorph Screening & Qualification in NCE/API Comprehensive screening and qualification of polymorphic forms to ensure optimal characteristics for NCE/API development. 3 Quantification & Establishment of Polymorphic Nature Advanced analytical techniques used to quantify and establish the polymorphic nature in NCE/API formulations. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Peptide Synthesis Technologies
Solid-phase, solution/liquid-phase, hybrid SPPS–LPPS, recombinant/fermentation, and native chemical ligation synthesis routes.
Source & evidence
Supplier website We offer solid-phase peptide synthesis (SPPS, both Fmoc and Boc strategies), solution/liquid-phase synthesis (LPPS), hybrid SPPS–LPPS for long and complex peptides, recombinant/fermentation-based routes, and native chemical ligation. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Analytical development and process optimization
Payload classes are supported by analytical development, impurity profiling, stability assessment, and process optimization.
Source & evidence
Supplier website Each payload class is supported by comprehensive analytical development, impurity profiling, stability assessment, and process optimization, ensuring consistent quality and reliable bulk supply. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Pharmaceutical manufacturing
Development and delivery of NCEs across clinical phases, and supply of KSMs, RSMs, advanced intermediates and final APIs.
Source & evidence
Supplier website Our state-of-the-art infrastructure enables us to meticulously design and execute the development and delivery of New Chemical Entities (NCEs) across all clinical phases. With a proven track record of successful regulatory audits, we are prepared to collaborate with our partners at any stage. Leveraging our expertise and strong analytical support, Shilpa pharma ensure seamless delivery of KSMs, RSMs, advanced intermediates, and final APIs, while avoiding supply chain hurdles and uncompromising on quality and timelines. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Process safety
Assessment of hazards and risks, development of controls, and evaluation of process conditions for plant-scale safety.
Source & evidence
Supplier website At Shilpa, our team will introspect the robustness of a developed route by identifying hazards, managing risks at an early stage, developing controls, evaluating and revising the conditions to make it safer and viable at plant scale. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Custom ADC payload co-development and manufacturing
Co-development and bulk manufacturing of novel or client-specific small-molecule warheads tailored to ADC constructs.
Source & evidence
Supplier website Proprietary & Custom Payloads: Co-development and bulk manufacturing of novel or client-specific small-molecule warheads tailored to unique ADC constructs. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
ADC payload manufacturing and bulk supply
Specialized large-scale ADC payload manufacturing and bulk production for pharmaceutical and biotech innovators.
Source & evidence
Supplier website Shilpa Pharma is a world-class CDMO offering specialized, large-scale ADC payload manufacturing in India, focused exclusively on bulk production for global pharmaceutical and biotech innovators. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Cleaning Method
Develops cleaning methods for intermediates and APIs to support residue removal and regulatory compliance.
Source & evidence
Supplier website Cleaning Method Develop effective cleaning methods for intermediates and APIs ensuring residue removal and regulatory compliance. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Structure Elucidation
Uses NMR, mass spectrometry, IR and UV-Visible spectroscopy to identify and confirm chemical structures.
Source & evidence
Supplier website At Shilpa Pharma, we use a range of advanced spectroscopic techniques—including NMR, mass spectrometry, IR, and UV-Visible spectroscopy—to accurately identify and confirm chemical structures. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Route scouting, process development, scale-up, and commercial supply
Integrated support from route scouting and process development through scale-up and commercial supply.
Source & evidence
Supplier website Shilpa Pharma Lifesciences supports 10+ active NCE programs, providing integrated services from route scouting and process development to scale-up and commercial supply. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Stability Studies
Stability storage studies include refrigerated, accelerated, intermediate and long-term conditions.
Source & evidence
Supplier website Stability Studies -20°C refrigerated storage 2°C to 8°C refrigerated storage 40°C/75%RH: Accelerated stability storage 30°C/65%RH: Intermediate stability storage 25°C/60%RH: Long term stability storage Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Biologics manufacturing
Biologics services include monoclonal antibodies, biosimilars, peptides, and recombinant proteins.
Source & evidence
Supplier website Yes, our CDMO biologics services include monoclonal antibodies, biosimilars, peptides, and recombinant proteins. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Formulation development
Formulation development for tablets, capsules, injectables, and advanced drug delivery systems.
Source & evidence
Supplier website Our team specializes in CDMO formulation development for tablets, capsules, injectables, and advanced drug delivery systems Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
CDMO services
Formulation development, process optimization, analytical support, and scalable manufacturing.
Source & evidence
Supplier website Our comprehensive CDMO services include formulation development, process optimization, analytical support, and scalable manufacturing Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
cGMP Peptide Manufacturing
Peptide manufacturing from pre-clinical and clinical batches through commercial-scale supply.
Source & evidence
Supplier website Our cGMP-compliant peptide manufacturing infrastructure is designed for flexibility, scalability, and regulatory readiness across every phase of drug development Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Custom development
Route scouting, process optimization, formulation development, and pilot-scale manufacturing.
Source & evidence
Supplier website Leveraging advanced R&D and GMP-certified facilities, we support every stage — from route scouting and process optimization to formulation development and pilot-scale manufacturing. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Process development
Development of NCE APIs across clinical phases, including IND-enabling toxicology batches.
Source & evidence
Supplier website With an accumulated knowledge of more than 30 years, dealing with various chemistries, we meticulously plan experiments with a prime focus on Process design, development and delivery of NCE API across all clinical phases including IND enabling Tox batch. Shilpa Pharma Lifesciences Limited website Checked 24 Oct 2026
Analytical Development
Analytical method development using RP-HPLC, LC-MS, and peptide mapping.
Supports 15 facts: Company name · Description · Biologics manufacturing · Formulation development · CDMO services · Custom development · US FDA Approved · EU GMP Certified
Supports 8 facts: Company name · Analytical and quality control services · Peptide CDMO · Pharmaceutical manufacturing · Process safety · Process development · Location: Raichur, India · Location: address
Supports 7 facts: Company name · Description · Process chemicals & gases · Solder, adhesives & tapes · Consumer electronics · Power electronics & energy · Location: Raichur, India